Emergen Research’s latest market research report, titled Global DNA RNA Banking Services Market, provides estimated market size and shares, latest industry trends, global market growth rates, key drivers and opportunities, constraints, product segmentation, and major market players. Cost structure, market size, competitive landscape, product portfolio and specifications, and company profiles.
This report is a fair prototype of the DNA RNA Banking Services-industry containing an in-depth study of the global DNA RNA Banking Services market. This report serves as a valuable source of data and information related to this industry. It covers various industry aspects with a particular focus on market scope and application areas. The report identifies the fundamental business strategies adopted by industry experts and offers an insightful study on the value chains and distribution channels of the global market. The report authors have also analyzed current industry trends, growth potential, current overview, and market limitations.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4284
The DNA RNA Banking Services Market is expected to grow from an estimated USD 7.9 billion in 2024 to USD 13.3 billion in 2033, at a CAGR of 6.00%.
The government’s increasing support for genomic research over the years, which has become a crucial aspect of precision medicine in general and genetics in particular, is one of the factors contributing to the expansion of the DNA RNA banking services industry.
Genomic data have been greatly invested in large-scale research projects for medical research purposes. For example, the United States alone hosts some of its foremost leaders, like the National Institutes of Health, leading a vast array of similar endeavors. Altogether, NIH’s program allocates over $1.5 billion for the systematic assembly of genetic, environmental and lifestyle information from over one million US residents.
The success of this program will be dependent on the availability of high-quality DNA and RNA samples, which will directly increase the market for DNA RNA banking services. Moreover, the UK Biobank, which is a project initiated by the UK government, has collected DNA samples from over 500,000 people.
This biobank contributes toward a valuable resource based on the genetics of many diseases so that research conducted on the large scale gets reaffirmation due to the significance played by the biobanks in research on large genomic level. This biobank’s data is currently being utilized by researchers across the world in their investigations regarding genetics.
Similarly, the European Commission is funding even more biobanking projects with the intent of improving research capacity at the whole European continent level. For example, the EBI grants access to genomic data in education and commerce and thereby contributes towards international researches in genomics.
These government-funded initiatives fuel the development of genomic science, thereby also increasing innovation in the biobanking sector. As such, it would increase the demand for special services related to DNA and RNA samples storage and handling in the 19th century.
However, as shown by these initiatives, investments by the government in genomics research have been key to the growth of DNA RNA banking services markets. Such investments create necessary infrastructure for storing large quantities of genetic information and encourage the collaboration of governments, academia, and private organizations.
This means that funding is going to be allocated towards precision medicine and will continue leading to further increased and heightened demand for full-range secure DNA RNA banking services, hence driving further acceleration in the market.
Key market aspects studied in the report:
Market Scope: The report explains the scope of various commercial possibilities in the global DNA RNA Banking Services market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.
Competitive Outlook: The leading companies operating in the DNA RNA Banking Services market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.
Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global DNA RNA Banking Services market.
Market Segmentation:
The report bifurcates the DNA RNA Banking Services market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
The DNA RNA banking services market is very competitive, with the presence of major players such as Thermo Fisher Scientific, Illumina, and Qiagen, which provide advanced genomic storage and processing solutions. The industry is growing, with biobanks, research institutions, and healthcare providers increasingly investing in genomic research. Government initiatives and regulatory support are accelerating growth.
With the advancement of genomic sequencing technologies and cloud storage solutions, the market is expected to grow continuously, especially in regions like Asia-Pacific, where demand for these services is growing rapidly.
In May 2023, Thermo Fisher Scientific announced the launch of its enhanced DNA and RNA storage solutions designed to support large-scale biobank operations. The new services incorporate cutting-edge next-generation sequencing (NGS) technology, ensuring higher accuracy and efficiency in storing and processing genomic data. This development aims to support research institutions and healthcare providers in advancing personalized medicine and genomic studies.
Some of the key companies in the global DNA RNA Banking Services market include:
- EasyDNA
- DNA Genotek Inc.
- 23andMe, Inc.
- GoodCell
- ProteoGenex
- US Biolab Corporation, Inc.
- Infinity Biologix
- Thermo Fisher Scientific, Inc.
- deCODE genetics
- Brooks Life Sciences
- LGC Biosearch Technologies
- PreventionGenetics
Target Audience of the Global DNA RNA Banking Services Market Report:
- Key Market Players
- Investors
- Venture capitalists
- Small- and medium-sized and large enterprises
- Third-party knowledge providers
- Value-Added Resellers (VARs)
- Global market producers, distributors, traders, and suppliers
- Research organizations, consulting companies, and various alliances interested in this sector
- Government bodies, independent regulatory authorities, and policymakers
-
Services Outlook (Revenue, USD Billion; 2020-2033)
- Transportation Service
- Processing Service
- Storage Service
- Quality Control Service
- Data Storage
- Others
-
Specimen Outlook (Revenue, USD Billion; 2020-2033)
- Blood
- Buccal Swabs & Hair Follicles
- Others
-
Application Outlook (Revenue, USD Billion; 2020-2033)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
-
End-use Outlook (Revenue, USD Billion; 2020-2033)
- Academic Research
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Centers
- Others
-
Regional Outlook (Revenue, USD Billion; 2020-2033)
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- North America
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/dna-rna-banking-services-market
Competitive Terrain:
The global DNA RNA Banking Services industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.
Advancements in Precision Medicine and Personalized Healthcare Boost the Market Growth
The fast growth in precision medicine and personalized health care is a significant driver of growth in the DNA RNA banking services market. Precision medicine is the kind of treatment where drugs are given to a patient according to their genetic makeup.
The approach has gained popularity all over the world, both at private institutions and government levels. DNA and RNA data are becoming crucial as they allow healthcare professionals to offer the best possible treatments and predict risks associated with the health condition.
A prime example of this is the National Institutes of Health’s (NIH) Precision Medicine Initiative, which is heavily investing in the infrastructure required to collect and analyze genetic data. The All of Us Research Program is a key part of this initiative, aiming to create a more comprehensive understanding of how individual genetics, lifestyle, and environment influence health outcomes.
As healthcare systems become more dependent on genetic data to provide personalized treatments to patients, the demand for DNA RNA banking services to store and process this data is expected to increase.
Pharmaceutical companies are also investing heavily in genomic research to develop targeted therapies for diseases such as cancer, cardiovascular conditions, and neurological disorders. The growing interest in gene therapies, such as the approval of CAR-T cell therapies, indicates the need for a source of genetic material that one can rely on.
With clinical trials demanding consistent, high-quality genetic samples, DNA and RNA banks are rapidly becoming an important part of this emerging field. Precision medicine and the use of genetic data in research and development are creating significant demand for DNA RNA banking services.
The market is being increased through investments by not only governments but also private pharmaceutical companies and healthcare organizations who are looking forward to exploiting genetic data to ensure better and more individualized treatments.
Key reasons to buy the Global DNA RNA Banking Services Market report:
- The latest report comprehensively studies the global DNA RNA Banking Services market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.
- The report offers an insightful analysis of the regional outlook of the market.
- It offers a detailed account of the end-use applications of the products & services offered by this industry.
- The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/4284
Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com